Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin vs Benzydamine for Radiation-Induced Oropharyngeal Mucositis
IRCT20211202053252N2Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Radiation-induced oropharyngeal mucositis and Malignant neoplasm of head comparing Silymarin with Benzydamine (2 arms). Started Aug 2024; status: completed.
02
Drugs
silymarinbenzydamine
03
Conditions
Radiation-induced oropharyngeal mucositisMalignant neoplasm of head
Beyond the preview
Go deeper on IRCT20211202053252N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211202053252N2.